http://www.advfn.com/nasdaq/rss.asp?symbol=IDIX Idenix Pharmaceuticals Company Newsfeed en Fri, 22 Mar 2013 17:40:51 EDT Fri, 22 Mar 2013 17:40:51 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=56885225&headline=idenix-loses-1st-stage-of-drug-compounds-patent-case http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=56885225&headline=idenix-loses-1st-stage-of-drug-compounds-patent-case <div class='newsbody'><pre> By Debbie Cai </pre> <p> The U.S. Patent and Trademark Office has decided against Idenix Pharmaceuticals Inc. (IDIX) in the first phase of a two-stage interference process regarding the biopharmaceutical company's patent applications for certain compounds useful in the treatment... Fri, 22 Mar 2013 17:40:51 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=56150152&headline=correction-to-u-s-hot-stock-futures-table http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=56150152&headline=correction-to-u-s-hot-stock-futures-table <div class='newsbody'><p> "U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH," at 6 a.m. EST, misstated the stock price for Idenix Pharmaceuticals Inc. (IDIX). Shares closed Monday at $4.73 and declined after hours. </p> <p> Subscribe to WSJ: http://online.wsj.com?mod=djnwires </p> <pre> </pre> </div> Tue, 05 Feb 2013 10:16:52 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=56144102&headline=u-s-hot-stock-futures-hot-stocks-to-watch http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=56144102&headline=u-s-hot-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies with shares expected to actively trade in Tuesday's session are Yum Brands Inc. (YUM), Idenix Pharmaceuticals Inc. (IDIX) and Hemispherx Biopharma Inc. (HEB). </p> <p> Yum Brands' fourth-quarter earnings slipped 5.3% as the fast-food chain's same-store sales... Tue, 05 Feb 2013 06:30:07 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=56138027&headline=u-s-hot-stocks-idenix-yum-brands-hologic-active-in-late-trading http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=56138027&headline=u-s-hot-stocks-idenix-yum-brands-hologic-active-in-late-trading <div class='newsbody'><p> U.S. stocks closed lower Monday, as the Dow Jones Industrial Average lost 130 points to 13880, the Standard &amp; Poor's 500 Index fell 17 points to 1496, and the Nasdaq Composite slipped 1.5% to 3131. Among the companies with shares actively trading after hours are Idenix Pharmaceuticals... Mon, 04 Feb 2013 18:27:22 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=56137626&headline=idenix-to-discontinue-development-of-two-hepatitis-c-treatments http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=56137626&headline=idenix-to-discontinue-development-of-two-hepatitis-c-treatments <div class='newsbody'><pre> By Nathalie Tadena and Kristin Jones </pre> <p> Idenix Pharmaceuticals Inc. (IDIX) said it will discontinue its clinical development program for two of its investigational treatments for hepatitis C, after the U.S. Food and Drug Administration said the treatments would remain... Mon, 04 Feb 2013 17:40:19 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=53951600&headline=idenix-fda-places-hepatitis-c-treatment-on-clinical-hold http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=53951600&headline=idenix-fda-places-hepatitis-c-treatment-on-clinical-hold <div class='newsbody'><pre> By Tess Stynes </pre> <p> Idenix Pharmaceuticals Inc. (IDIX) said the Food and Drug Administration placed a clinical hold on one of its treatments for hepatitis C, the latest setback for the drug developer. </p> <p> The clinical hold on the treatment--IDX19368--is related... Mon, 27 Aug 2012 09:41:20 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=53672691&headline=us-hot-stock-futures-hot-stocks-to-watch http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=53672691&headline=us-hot-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies with shares expected to actively trade in Wednesday's session are Garmin Ltd. (GRMN), DreamWorks Animation SKG Inc. (DWA) and Laboratory Corp. of America Holdings (LH). </p> <p> Shares of Garmin traded higher premarket after second-quarter earnings surged... Wed, 01 Aug 2012 09:36:08 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=52822414&headline=idenix-89-of-patients-in-hep-c-trial-arm-achieved-viral-suppression http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=52822414&headline=idenix-89-of-patients-in-hep-c-trial-arm-achieved-viral-suppression <div class='newsbody'><pre> By Ben Fox Rubin </pre> <p> Biopharmaceutical firm Idenix Pharmaceuticals Inc. (IDIX) has provided some results from an ongoing Phase 2b study of its lead hepatitis C drug, IDX184, showing positive suppression of the virus. </p> <p> Shares jumped 15% after hours Tuesday to... Tue, 19 Jun 2012 18:22:23 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=50670696&headline=hepatitis-c-drug-developers-shares-soar-after-bristol-deal http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=50670696&headline=hepatitis-c-drug-developers-shares-soar-after-bristol-deal <div class='newsbody'><p> --Shares of two players developing hepatitis C treatments jump after news of peer being acquired </p> <p> --Bristol-Myers is paying a 163% premium to acquire Inhibitex </p> <p> --Analysts say significant interest remains for hepatitis C-focused biotech companies </p> <pre> By... Mon, 09 Jan 2012 10:56:05 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=50668484&headline=us-stock-futures-hot-stocks-to-watch http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=50668484&headline=us-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies whose shares are expected to actively trade in Monday's session are Idenix Pharmaceuticals Inc. (IDIX), Inhibitex Inc. (INHX) and GlaxoSmithKline PLC (GSK, GSK.LN). </p> <p> Idenix surged 44% to $10.16 in recent premarket trading in the wake of fellow Hepatitis... Mon, 09 Jan 2012 09:07:39 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=47225610&headline=idenix-pharma-18-3m-share-offering-priced-at-14-discount http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=47225610&headline=idenix-pharma-18-3m-share-offering-priced-at-14-discount <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> Idenix Pharmaceuticals Inc. (IDIX) said its 18.3 million-share stock offering priced at a 14% discount to Thursday's $3.24 close, as the company joins a long list of firms that have tapped markets in recent months to raise additional cash. </p> <p>... Fri, 08 Apr 2011 09:41:48 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=44269378&headline=idenix-says-fda-put-studies-of-hepatitis-c-drug-on-hold http://www.advfn.com/nasdaq/StockNews.asp?stocknews=IDIX&article=44269378&headline=idenix-says-fda-put-studies-of-hepatitis-c-drug-on-hold <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Idenix Pharmaceuticals Inc. (IDIX) was verbally notified by the U.S. Food and Drug Administration that its drug programs to treat the virus that causes hepatitis C are on hold. </p> <p> The biopharmaceutical company said the delay came after Idenix... Tue, 07 Sep 2010 08:03:27 EDT